Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Company's Life Sciences segment provides stereo microscopes, and filtration, separation, and purification technologies. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and flow cytometry products. The Company offers analytical instruments, reagents, consumables, software, and services for critical care settings. Its Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent dental disease. The Company's Environmental and Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water. This segment also provides equipment, software, services, and consumables for packaging, printing, marking, coding, and traceability applications.

TypePublic
HQWashington, US
Founded1984
Size (employees)67,000 (est)+9%
Websitedanaher.com
Danaher was founded in 1984 and is headquartered in Washington, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Danaher

Thomas Joyce

Thomas Joyce

President, Chief Executive Officer, Director
William Daniel

William Daniel

EVP
Brian Ellis

Brian Ellis

Senior Vice President, General Counsel
Angela Lalor

Angela Lalor

Senior Vice President, Human Resources
Daniel Raskas

Daniel Raskas

Senior Vice President, Corporate Development
Daniel Comas

Daniel Comas

Chief Financial Officer, Executive Vice President
Show more

Danaher Office Locations

Danaher has offices in New Delhi, Shanghai, Washington, Mumbai and in 1 other location
Washington, US (HQ)
2200 Pennsylvania Avenue, NW Suite 800W
Shanghai, CN
Shanghai One Site Room 602, Bldg 2, 518 North Fuquan Road IBP, Changning District
Mumbai, IN
77, North Avenue 3, 7th Floor Maker Maxity, Bandra Kurla Complex Bandra
New Delhi, IN
5th Floor, Aggarwal Corporate Tower 23, Rajendra Place
Sunbury-on-Thames, GB
5 Windmill Business Village Brooklands Close
Show all (5)
Report incorrect company information

Danaher Financials and Metrics

Danaher Revenue

Embed Graph
Danaher's revenue was reported to be $18.33 b in FY, 2017 which is a 8.6% increase from the previous period.
USD

Revenue (Q2, 2018)

5 b

Gross profit (Q2, 2018)

2.8 b

Gross profit margin (Q2, 2018), %

56.6%

Net income (Q2, 2018)

673.8 m

EBIT (Q2, 2018)

867.5 m

Market capitalization (20-Sep-2018)

75.6 b

Closing stock price (20-Sep-2018)

108

Cash (29-Jun-2018)

904 m

EV

86 b
Danaher's current market capitalization is $75.6 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

12.9 b14.4 b16.9 b18.3 b

Revenue growth, %

4%12%17%9%

Cost of goods sold

6 b6.7 b7.5 b8.1 b

Gross profit

6.8 b7.8 b9.3 b10.2 b
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

4.7 b5 b3.5 b3.9 b4.2 b4.1 b4.2 b4.5 b4.5 b4.7 b5 b

Cost of goods sold

2.2 b2.3 b1.6 b1.8 b1.9 b1.8 b1.9 b2 b2 b2.1 b2.2 b

Gross profit

2.5 b2.6 b1.9 b2.2 b2.4 b2.3 b2.3 b2.5 b2.5 b2.6 b2.8 b

Gross profit Margin, %

53%53%54%55%56%55%56%55%56%56%57%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

3 b790.8 m963.7 m630.3 m

Accounts Receivable

3.4 b3 b3.2 b3.5 b

Prepaid Expenses

952.7 m889.5 m805.9 m857.1 m

Inventories

1.8 b1.6 b1.7 b1.8 b
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

2.5 b3.3 b1.8 b664.3 m4.1 b971.4 m803.9 m726.4 m648.6 m1 b904 m

Accounts Receivable

3.4 b3.6 b3.9 b3.9 b4 b3.1 b3 b3.2 b3.3 b3.3 b3.3 b

Prepaid Expenses

919.3 m835.1 m851.6 m974 m898.4 m727.8 m715.2 m523.7 m464.7 m809.6 m732 m

Inventories

1.9 b1.9 b2.3 b2.2 b2.2 b1.7 b1.8 b1.8 b1.9 b1.9 b2 b
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

2.6 b3.4 b2.6 b2.5 b

Depreciation and Amortization

718.1 m880.8 m1.1 b1.2 b

Inventories

68.8 m146.5 m9.4 m(27.4 m)

Accounts Payable

79.7 m50.3 m78.1 m(54.4 m)
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

569.8 m1.3 b2.7 b758.4 m1.4 b1.8 b506.1 m1.1 b1.6 b566.6 m1.2 b

Depreciation and Amortization

235.5 m472.5 m608 m267.7 m545.3 m822.5 m305.6 m608.8 m427.3 m320.8 m655.4 m

Inventories

(111.1 m)(102.6 m)(40.8 m)(85.6 m)(104.9 m)(138.5 m)(56.9 m)(45.4 m)(98.2 m)(128.9 m)(197.1 m)

Accounts Payable

(84.8 m)(74.8 m)(142.2 m)(116 m)(42.7 m)(38.1 m)(90.9 m)(104.1 m)(48.5 m)51.4 m87 m
USDY, 2018

EV/EBIT

99.1 x

EV/CFO

46.1 x

Debt/Equity

0.4 x

Debt/Assets

0.2 x

Financial Leverage

1.8 x
Show all financial metrics

Danaher Operating Metrics

Danaher's Backlog was reported to be $2.7b in FY, 2017.
FY, 2014FY, 2015FY, 2016FY, 2017

Backlog

$2.36 b$1.76 b$2.67 b$2.70 b

Facilities

273 336 242 248

Countries

50 50 60 60
Show all operating metrics

Danaher Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Advanced Vision TechnologyMarch 06, 2017$100 m
PhenomenexOctober 12, 2016
CepheidSeptember 06, 2016$4 b
LaetusDecember 02, 2015
SutronJune 22, 2015
PallMay 13, 2015$13.80 b
Nobel BiocareSeptember 15, 2014$2.20 b
Navman WirelessJanuary 29, 2013
Navman Wireless OEM SolutionsMay 29, 2012
IRIS InternationalApril 10, 2012
Show more

Danaher Revenue Breakdown

Embed Graph

Danaher revenue breakdown by business segment: 21.7% from Environmental & Applied Solutions, 15.3% from Dental, 31.9% from Diagnostics and 31.2% from Life Sciences

Danaher revenue breakdown by geographic segment: 40.6% from All Other, 11.0% from China, 37.3% from United States, 6.3% from Germany and 4.8% from Other

Report incorrect company information

Danaher News and Updates

Global Rapid Microbiology Testing Market 2018-2023: Major Players Profiled Include bioMrieux, Abbott Laboratories, Danaher, and Becton, Dickinson and Co

DUBLIN, Sept 19, 2018 /PRNewswire/ -- The "Rapid Microbiology Testing Market by Method (Growth, Viability), Product (Automated Microbial Identification & AST System, PCR, Reagent), Application (Clinical Diagnosis, Environmental), End User (Labs, Hospitals, Industry) - Global Forecast to...

POC Molecular Diagnostics 2018 Global Market Key Players – Abbott, bioMerieux, Danaher, BD, Certest Biotec, F. Hoffmann-La Roche – Analysis and Forecast to 2025

WiseGuyRerports.com Presents “Global POC Molecular Diagnostics Market Size, Status and Forecast 2018-2025” New Document to its Studies Database Posted via Industry Today. Follow us on Twitter @IndustryToday

Danaher To Webcast Mid-Year Investor And Analyst Meeting At Pall

WASHINGTON, Sept. 17, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of its Mid-Year Investor and Analyst Meeting at Pall on September 18, 2018 beginning at 12:00 p.m. ET. The event will be held at Danaher's Pall facility in Westborough, Massachusetts...

Global Hollow Fiber Filtration Market to 2023 - Key Players Include Asahi Kasei, Repligen, GE Healthcare and Danaher

DUBLIN, Sept. 17, 2018 /PRNewswire/ -- The "Hollow Fiber Filtration Market by Technique (Microfiltration, Ultrafiltration), Material (Polymer, Ceramic), Application (Harvest & Clarification, Concentration, Perfusion), End User (Pharmaceutical Manufacturer, CRO, CMO) - Global Forecast to...

Global POC HIV Testing Market 2018-2022 - Key Vendors are Abbott, BD, bioMrieux, Danaher & F. Hoffmann-La Roche

DUBLIN, Sept. 12, 2018 /PRNewswire/ -- The "Global POC HIV Testing Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global POC HIV Testing Market to grow at a CAGR of 7.03% during the period 2018-2022. Global POC HIV Testing Market 2018-2022, has been...

Danaher Announces Quarterly Dividend

WASHINGTON, Sept. 11, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on October 26, 2018 to holders of record on September 28, 2018. ABOUT DANAHER Danaher is a global...
Show more
Report incorrect company information

Danaher Company Life and Culture

Report incorrect company information